Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Change in Acquisitions & Divestments (2025)

Immunocore Holdings' Change in Acquisitions & Divestments history spans 1 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $2.0 million; the TTM value through Dec 2025 reached $18.0 million, changed N/A, while the annual FY2025 figure was $18.0 million, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $2.0 million at Immunocore Holdings, down from $6.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $10.0 million in Q1 2025 and bottomed at $2.0 million in Q4 2025.